Maintaining Moderate Platelet Aggregation and Improving Metabolism of Endothelial Progenitor Cells Increase the Patency Rate of Tissue-Engineered Blood Vessels

Tissue Engineering - Part A

Volumn 21, Issue 13-14, 2015, Pages 2001-2012

  Wu, Yangxiao ^a   Li, Li ^a   Chen, Wen ^a   Zeng, Wen ^a   Zeng, Lingqin ^a   Wen, Can ^a   Zhu, Chuhong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL PROSTHESES; ENDOTHELIAL CELLS; METABOLISM; PLATELETS; TISSUE;

ACTIVATING PLATELETS; CAROTID ARTERY; DELAYED RELEASE; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIAL PROGENITOR CELLS (EPCS); ENDOTHELIALIZATION; PLATELET AGGREGATION; TISSUE ENGINEERED BLOOD VESSELS;

BLOOD VESSELS;

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; SEROTONIN; THROMBOXANE A2; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; ADENYLATE KINASE; AICA RIBONUCLEOTIDE; RIBONUCLEOTIDE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENERGY METABOLISM; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE METABOLISM; TISSUE ENGINEERED BLOOD VESSEL; TISSUE ENGINEERING; ANALOGS AND DERIVATIVES; ANASTOMOSIS; ANIMAL; BIOLOGICAL MODEL; BLOOD VESSEL PROSTHESIS; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; ENZYME ACTIVATION; HUMAN; METABOLISM; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; TRANSPLANTATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR PATENCY;

RATTUS;

ADENYLATE KINASE; AMINOIMIDAZOLE CARBOXAMIDE; ANASTOMOSIS, SURGICAL; ANIMALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL PROGENITOR CELLS; ENZYME ACTIVATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; PARACRINE COMMUNICATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; RATS, SPRAGUE-DAWLEY; RIBONUCLEOTIDES; SEROTONIN; SIGNAL TRANSDUCTION; THROMBOXANE A2; TISSUE ENGINEERING; VASCULAR PATENCY;

EID: 84936869180     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2015.0013     Document Type: Article

References (26)

1. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Judd, S.E., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Mackey, R.H., Magid, D.J., Marcus, G.M., Marelli, A., Matchar, D.B., McGuire, D.K., Mohler, E.R., 3rd, Moy, C.S., Mussolino, M.E., Neumar, R.W., Nichol, G., Pandey, D.K., Paynter, N.P., Reeves, M.J., Sorlie, P.D., Stein, J., Towfighi, A., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., Turner, M.B.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129, e28, 2014.
2. Bordenave, L., Menu, P., and Baquey, C. Developments towards tissue-engineered, small-diameter arterial substitutes. Expert Rev Med Devices 5, 337, 2008.
3. Li, S., Sengupta, D., and Chien, S. Vascular tissue engineering: from in vitro to in situ. Wiley Interdiscip Rev Syst Biol Med 6, 61, 2014.
4. L'Heureux, N., Paquet, S., Labbe, R., Germain, L., and Auger, F.A. A completely biological tissue-engineered human blood vessel. FASEB J 12, 47, 1998.
5. Cimmino, G., and Golino, P. Platelet biology and receptor pathways. J Cardiovasc Transl Res 6, 299, 2013.
6. Langer, H., May, A.E., Daub, K., Heinzmann, U., Lang, P., Schumm, M., Vestweber, D., Massberg, S., Schonberger, T., Pfisterer, I., Hatzopoulos, A.K., and Gawaz, M. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 98, e2, 2006.
7. Raz, O., Lev, D.L., Battler, A., and Lev, E.I. Pathways mediating the interaction between endothelial progenitor cells (EPCs) and platelets. PLoS One 9, e95156, 2014.
8. Ranjan, A.K., Kumar, U., Hardikar, A.A., Poddar, P., Nair, P.D., and Hardikar, A.A. Human blood vessel-derived endothelial progenitors for endothelialization of small diameter vascular prosthesis. PLoS One 4, e7718, 2009.
9. Avci-Adali, M., Ziemer, G., and Wendel, H.P. Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization-a review of current strategies. Biotechnol Adv 28, 119, 2010.
10. Pearson, J.D. Endothelial progenitor cells-an evolving story. Microvasc Res 79, 162, 2010.
11. Goh, E.T., Wong, E., Farhatnia, Y., Tan, A., and Seifalian, A.M. Accelerating in situ endothelialisation of cardiovascular bypass grafts. Int J Mol Sci 16, 597, 2015.
12. Burgess, R.J., Agathocleous, M., and Morrison, S.J. Metabolic regulation of stem cell function. J Intern Med 276, 12, 2014.
13. Matot, I., and Jurim, O The protective effect of acadesine on lung ischemia-reperfusion injury.AnesthAnalg 92, 590, 2001
14. Cronstein, B.N., and Kamen, B.A. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agent for therapy of patients with acute lymphoblastic leukemia: are we there and are there pitfalls? J Pediatr Hematol Oncol 29, 805, 2007.
15. Liu, Y., Oh, S.J., Chang, K.H., Kim, Y.G., and Lee, M.Y. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole. Biochem Pharmacol 86, 914, 2013.
16. Corton, J.M., Gillespie, J.G., Hawley, S.A., and Hardie, D.G. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229, 558, 1995.
17. Steinberg, G.R., and Kemp, B.E. AMPK in health and disease. Physiol Rev 89, 1025, 2009.
18. Hardie, D.G. AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol 33C, 1, 2014.
19. Zeng, W., Yuan, W., Li, L., Mi, J., Xu, S., Wen, C., Zhou, Z., Xiong, J., Sun, J., Ying, D., Yang, M., Li, X., and Zhu, C. The promotion of endothelial progenitor cells recruitment by nerve growth factors in tissue-engineered blood vessels. Biomaterials 31, 1636, 2010.
20. Zeng, W., Wen, C., Wu, Y., Li, L., Zhou, Z., Mi, J., Chen, W., Yang, M., Hou, C., Sun, J., and Zhu, C. The use of BDNF to enhance the patency rate of small-diameter tissueengineered blood vessels through stem cell homing mechanisms. Biomaterials 33, 473, 2012.
21. Galasso, G., De Rosa, R., Ciccarelli, M., Sorriento, D., Del Giudice, C., Strisciuglio, T., De Biase, C., Luciano, R., Piccolo, R., Pierri, A., Di Gioia, G., Prevete, N., Trimarco, B., Piscione, F., and Iaccarino, G. beta2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis. Circ Res 112, 1026, 2013.
22. Spadaccio, C., Chello, M., Trombetta, M., Rainer, A., Toyoda, Y., and Genovese, J.A. Drug releasing systems in cardiovascular tissue engineering. J Cell MolMed 13, 422, 2009.
23. Rivera, J., Lozano, M.L., Navarro-Nunez, L., and Vicente, V. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 94, 700, 2009.
24. Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C.H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338, 557, 1989.
25. George, A.L., Bangalore-Prakash, P., Rajoria, S., Suriano, R., Shanmugam, A., Mittelman, A., and Tiwari, R.K. Endothelial progenitor cell biology in disease and tissue regeneration. J Hematol Oncol 4, 24, 2011.
26. Birbrair, A., Zhang, T., Wang, Z.M., Messi, M.L., Mintz, A., and Delbono, O. Pericytes at the intersection between tissue regeneration and pathology. Clin Sci (Lond) 128, 81, 2015.